RxDoctor Payments Data

Muhammad Khawar, MD

Critical Care Medicine · Cincinnati, OHNPI 1740544824

Payments from drug & device makers

What this record shows

This record is dominated by education: $2,767 of the $4,603 with a category attached, or 60.1%. Intuitive Surgical accounts for 64.4% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $4,166, more than ten times the $91 reported in 2023. Among critical care medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,603in general payments, 2019–2025

Across 100 payments — averaging $46.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • GSK$492
  • Regeneron Healthcare Solutions, Inc.$303
  • AstraZeneca$274
  • Sanofi$191
  • Sanofi-aventis U.S. LLC$79
  • plus $300 from 8 others

What the payments were for

  • Travel & lodging$46410%
  • Food & beverage$1,37330%
  • Education$2,76760%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,603 in reported general payments places this provider in the 90th percentile of 285 critical care medicine providers in Ohio.

See all critical care medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$59,255
Medicare patients
201
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$24,106
Spiriva HandihalerTiotropium Bromide11$5,564
SymbicortBudesonide/Formoterol Fumarate21$4,792
Albuterol Sulfate HfaAlbuterol Sulfate31$612
Prednisone14$32

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$492$24,10632 claims
AstraZenecaSymbicort$274$4,79221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 285 critical care medicine providers in Ohio.

Other critical care medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →